Literature DB >> 19320659

Is early onset breast cancer with no family history a good criterion for testing BRCA1 and BRCA2 genes? A small population-based study.

E Beristain, C Martínez-Bouzas, G Mallabiabarrena, M I Tejada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19320659     DOI： 10.1111/j.1399-0004.2008.01137.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


× No keyword cloud information.
  3 in total

1.  LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not.

Authors:  E Beristain; I Guerra; N Vidaurrazaga; J Burgos-Bretones; M I Tejada
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

2.  Breast and ovarian cancer risk evaluation in families with a disease-causing mutation in BRCA1/2.

Authors:  Elena Beristain; Berta Ibáñez; Itziar Vergara; Cristina Martínez-Bouzas; Isabel Guerra; Maria Isabel Tejada
Journal:  J Community Genet       Date:  2010-08-09

3.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.